BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, July 26, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
Dec. 6, 2013
View Archived Issues
Washington roundup: NPWT scores big in Medicare outpatient final rule for CY '14
Read More
Introducing our new look
Read More
Financings roundup: Endologix reveals pricing of public offering of senior notes
Read More
Report from europe: Medtronic gets approval for flexible 4 Fr Symplicity catheter
Read More
Deals roundup: McKesson launches public takeover offer for Celesio
Read More
Agreements/contracts: Sagentia, SetPoint develop neuromodulation device
Read More
HIT roundup: VitalHealth launches patient engagement solution in U.S.
Read More
Patent watch: NeuroSigma gains patent to cover the use of TNS
Read More
Med-tech notes
Read More
People in Places
Read More
Investigators begin Activa study with first implants of device
A new study conducted by a group of independent investigators could have huge implications for Medtronic's (Minneapolis) Activa PC+S DBS system. Investigators reported the first U.S. implants of the device.
Read More
Nixing bias from RDN trials may produce more modest outcomes
Read More
Product briefs
Read More
MDD's Diagnostics Extra
Read More
